Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Omega 3 fatty acids capsules 1 g once daily: Participants of the study will be given 1 gram of omega 3 fatty acid- fish oil capsule per day once daily to take orally for 8 weeks.
Contro
Sponsors
Dr E Hephzibah Magdalene
Eligibility
Inclusion criteria
Inclusion criteria: ï?·Patients of Type 2 Diabetic Dyslipidemia on anti-diabetic and hypolipidemic drugs for more than 3 months. ï?·Patients of non- diabetic dyslipidemia.
Exclusion criteria
Exclusion criteria: 1.Patients with sea-food allergy 2.Patients with bleeding disorders, liver diseases. 3.Patients on anti-coagulants, oral contraceptive pills and immunosuppressants. 4.Patients who are not willing to give consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PRIMARY ENDPOINT: Lowering of plasma triglycerides from baseline through 8 weeks. Timepoint: Visit 1(0 weeks): Screening, baseline investigations,issue of drug. Visit 2( 3 days) : Enrollment, Randomisation Visit 3( 4 weeks): Vitals, Adverse event monitoring, Investigations Visit 4(8 weeks): Vitals, investigations, Adverse event monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| ï?·Lowering of total cholesterol, LDL,VLDL from baseline through 8 weeks.Timepoint: Visit 1(0 weeks): Screening, baseline investigations,issue of drug. Visit 2( 3 days) : Enrollment, Randomisation Visit 3( 4 weeks): Vitals, Adverse event monitoring, Investigations Visit 4(8 weeks): Vitals, investigations, Adverse event monitoring. | — |
Countries
India
Contacts
Public ContactDr E Hephzibah Magdalene
Madras Medical College
Outcome results
None listed